Downregulation of CFTR Is Involved in the Formation of Hypertrophic Scars

Area of Science:

• Wound healing research
• Dermatology
• Fibroproliferative disorders

Background:

• Hypertrophic scars (HTSs) are a common fibroproliferative disorder with incompletely understood pathogenesis.
• The role of specific ion channels, like CFTR, in scar tissue development is an emerging area of investigation.

Purpose of the Study:

• To investigate the role of cystic fibrosis transmembrane conductance regulator (CFTR) downregulation in the development of hypertrophic scars.
• To elucidate the impact of CFTR deficiency on fibroblast function and collagen deposition under mechanical stress.

Main Methods:

• Analysis of CFTR expression in human hypertrophic scars using microarray, RT-PCR, and immunofluorescence.
• Utilized wild-type and CFTR-mutant (ΔF508) mice subjected to mechanical overloading for wound healing assessment.
• Quantified collagen deposition, collagen type 1/3 ratios, and inflammatory/proliferative markers via histological staining and RT-PCR; assessed fibroblast collagen expression via Western blotting.

Main Results:

• CFTR expression was significantly downregulated in human hypertrophic scars.
• ΔF508 mice showed delayed wound healing, larger scars, increased collagen deposition, and a higher Col1/Col3 ratio.
• CFTR deficiency in fibroblasts led to reduced Collagen Type 3 expression and an increased Col1/Col3 ratio, particularly under mechanical stress, alongside elevated proinflammatory markers.

Conclusions:

• Downregulation of CFTR is implicated in hypertrophic scar formation.
• CFTR deficiency impairs fibroblast function, leading to altered collagen synthesis (lower Col3, higher Col1/Col3 ratio) and exacerbating HTS development under mechanical load.
• Targeting CFTR may offer a therapeutic strategy for managing hypertrophic scars.